Systemic Thyroid Hormone Status During Levothyroxine Therapy In Hypothyroidism: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
CONTEXT: The standard of care for overt hypothyroidism is levothyroxine at doses that normalize serum TSH levels. Whether this approach universally restores thyroid hormone signaling is unknown. OBJECTIVE: To review studies of overt hypothyroidism in which participants were treated with levothyroxine to normalize serum TSH levels and measured other objective markers of thyroid hormone signaling. DESIGN: Databases were searched for studies that reported objective markers of thyroid hormone signaling (serum low-density lipoprotein (LDL), total cholesterol (TC), sex hormone-binding globulin (SHBG), creatine kinase and/or ferritin levels; cognition, energy expenditure, and/or renal function) in levothyroxine monotherapy for overt, primary hypothyroidism among nonpregnant adults with normal serum TSH levels. For studies with LDL, TC and SHBG outcomes, data were pooled using random effects meta-analysis. RESULTS: A total of 99 studies met inclusion criteria, including 65 that reported serum cholesterol data. Meta-analysis showed that levothyroxine-treated hypothyroid participants with normal serum TSH levels had 3.31 ± 1.64 mg/dL higher serum LDL levels (p=0.044) and 9.60 ± 3.55 mg/dL higher serum TC levels (p=0.007) compared to controls. In studies that did not concomitantly assess healthy controls, serum LDL levels were 138.3 ± 4.6 mg/dL (p<0.001) and serum TC levels were 209.6 ± 3.4 mg/dL (p<0.001). Meta-analysis of 2 studies showed no significant difference between SHBG levels of levothyroxine-treated participants and controls. CONCLUSIONS: In studies that utilized levothyroxine monotherapy at doses that normalized the serum TSH for overt, primary hypothyroidism, not all systemic biological markers of thyroid hormone signaling were normalized, including serum LDL and TC levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While LT4 therapy is very effective in normalizing serum TSH levels, it fails to restore euthyroidism in some tissues based on an array of metabolic parameters such as serum cholesterol levels and other biomarkers that remain abnormal in LT4-treated patients, despite a normal serum TSH (14–16).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a 5% increase in BMI, increased cholesterol”
From Designing a combined liothyronine (LT3), L- thyroxine (LT4) trial in symptomatic hypothyroid subjects on LT4 - the importance of patient selection, choice of LT3 and trial design (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While LT4 therapy is very effective in normalizing serum TSH levels, it fails to restore euthyroidism in some tissues based on an array of metabolic parameters such as serum cholesterol levels and other biomarkers that remain abnormal in LT4treated patients, despite a normal serum TSH [14-16].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“have higher serum cholesterol and low density lipoprotein levels (19–21)”
From Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism (2020) · cites this paper as [19]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Additionally, a meta-analysis of 65 studies revealed that both total cholesterol and LDL cholesterol concentrations remain elevated, even after serum TSH has been normalised.177”
From Hypothyroidism (2024) · cites this paper as [177]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“A systematic literature search was performed in adherence with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (18, 19).”
MethodThe Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Law, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
The epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094 · cited 2×
“clinically important, this might support the need for amendment of hypothyroidism (2) and lipid (90) guidelines to address screening of serum lipid profiles and”
BackgroundBASIC AND CLINICAL ENDOCRINOLOGY
(1984) · Endocrine Disorders · doi:10.1016/b978-0-407-00346-0.50001-5 · Cited by 612
Research works printed but not linked: 5
- Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, Cooper DS, Kim BW, Peeters RP, Rosenthal MS, Sawka AM. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-1751.
- Medicines Use and Spending in the U.S. A Review of 2016 and Outlook to 2021. QuintilesIMS Institute. Durham, NC: IQVIA Institute for Human Data Science; ed2017.
- Ali A, Sattar A, Myuhammad A, Hameed A, Farooq M. Effect of thyroid hormone replacement therapy on lipid profile in primary hypothyroidism. Pak J Med Health Sci. 2013;7(1):127-129.
- Alaghband-Zadeh J, Wiseman SA, Greenhalgh RM, Carter GD, Powell JT, Fowler PB. L-Thyroxine reduces serum apolipoprotein b and limits progression of arterial disease in women claudicants with elevated serum thyroid-stimulating hormone. Eur J Intern Med. 1992;3:213-218.
- Sampaolo G, Campanella N, Catozzo V, Ferretti M, Vichi G, Morosini P. Relationship between hypothyroidism and cholesterol out of the records of 1756 patients [in Italian]. Recenti Prog Med. 2014;105(2):79-82.
Cited by
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Self-citationJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
Self-citationTreatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis
Kotwal, A., Cortes, T., Genere, N., Hamidi, O., Jasim, S., Newman, C. B., Prokop, L. J., Murad, M. H., & Alahdab, F. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa672 · Cited by 162
Taylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers
Jonklaas, J., & Razvi, S. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30371-1 · Cited by 100
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Self-citationIndividualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
Ettleson, M. D., & Bianco, A. C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa430 · Cited by 75
Self-citationTaylor, P. N., Lansdown, A., Witczak, J., Khan, R., Rees, A., Dayan, C. M., & Okosieme, O. (2023) · Thyroid Research · doi:10.1186/s13044-023-00149-5 · Cited by 72
“A meta-analysis of 65 studies that compared 1878 levothyroxine-treated patients to 14,493 healthy controls revealed that both total-cholesterol and LDL-cholesterol remain elevated, after serum TSH has been normalized [120] likely reflecting lower hepatic T3 status.”
T3 levels and thyroid hormone signaling
Salas-Lucia, F., & Bianco, A. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044691 · Cited by 66
“Second, LT4-treated patients with normal serum TSH weigh about 10 pounds more and exhibit higher levels of serum low-density lipoprotein and total cholesterol when compared to controls (70), despite exhibiting a higher utilization of statins”
BackgroundSelf-citationBrain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
Samuels, M. H., & Bernstein, L. J. (2022) · Thyroid · doi:10.1089/thy.2022.0139 · Cited by 64
Primary Hypothyroidism and Alzheimer’s Disease: A Tale of Two
Alanazi, F., Al-Kuraishy, H. M., Alexiou, A. T., Papadakis, M., Ashour, M. H. M., Alnaaim, S. A., Elhussieny, O., Saad, H. M., & Batiha, G. E. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01392-y · Cited by 60
Liothyronine and Desiccated Thyroid Extract in the Treatment of Hypothyroidism
Idrees, T., Palmer, S., Maciel, R. M. B., & Bianco, A. C. (2020) · Thyroid® · doi:10.1089/thy.2020.0153 · Cited by 58
Self-citationThe relevance of T3 in the management of hypothyroidism
Salvatore, D., Porcelli, T., Ettleson, M. D., & Bianco, A. C. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00004-3 · Cited by 41
Self-citationIndividualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 41
Emerging Therapies in Hypothyroidism
Bianco, A. C. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-060622-101007 · Cited by 44
Self-citationT4 + T3 combination therapy: any progress?
Wiersinga, W. M. (2019) · Endocrine · doi:10.1007/s12020-019-02052-2 · Cited by 35
Evaluating health outcomes in the treatment of hypothyroidism
Ettleson, M. D., & Papaleontiou, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1026262 · Cited by 36
Chazova, I. E., Михайловна, Ч. Н., Blinova, N. V., Belaya, Z. E., Danilov, N. M., Elfimova, E. M., Litvin, A. Y., Rozhinskaya, L. Y., Sviridenko, N. Y., Швецов, М. Ю., et al. (2023) · Eurasian heart journal · doi:10.38109/2225-1685-2023-1-6-65 · Cited by 36
Critical Approach to Hypothyroid Patients With Persistent Symptoms
Biondi, B., Celi, F. S., & McAninch, E. A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad224 · Cited by 34
Self-citationLong-term thionamide antithyroid treatment of Graves' disease
Azizi, F., Abdi, H., Amouzegar, A., & Moeini, A. S. H. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101631 · Cited by 31
Sustained release T3 therapy: animal models and translational applications
Idrees, T., Price, J. D., Piccariello, T., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00544 · Cited by 30
Self-citationThe Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy
McAninch, E. A., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00446 · Cited by 24
Self-citationAlomair, B. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alshammari, M. A., Alexiou, A. T., Papadakis, M., Saad, H. M., & Batiha, G. E. (2024) · Thyroid Research · doi:10.1186/s13044-024-00199-3 · Cited by 27
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease
Azizi, F., Mehran, L., Abdi, H., & Amouzegar, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae456 · Cited by 26
Lee, Y. K., Lee, H., Han, S., Jung, H., Shin, D. Y., Nam, K.-H., Chung, W. Y., & Lee, E. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081106 · Cited by 24
“showed that levothyroxine-treated patients with normal serum TSH levels had higher serum total cholesterol and LDL-cholesterol levels than did healthy controls [6].”
BackgroundMuraca, E., Ciardullo, S., Oltolini, A., Zerbini, F., Bianconi, E., Perra, S., Villa, M., Cannistraci, R., Castoldi, G., Pizzi, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa097 · Cited by 24
Casula, S., Ettleson, M. D., & Bianco, A. C. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.003 · Cited by 21
Self-citationDumitrescu, A. M., Hanlon, E. C., Arosemena, M., Duchon, O., Ettleson, M., Giurcanu, M., & Bianco, A. C. (2022) · Thyroid · doi:10.1089/thy.2021.0304 · Cited by 20
Self-citationSystemic Thyroid Hormone Status in Treated Graves’ Disease
Azizi, F., Amouzegar, A., Tohidi, M., Hedayati, M., Cheraghi, L., & Mehrabi, Y. (2019) · Intern J Endocrinol Metab · doi:10.5812/ijem.95385 · Cited by 19
Ito, M., Kawasaki, M., Danno, H., Kohsaka, K., Nakamura, T., Hisakado, M., Yoshioka, W., Kasahara, T., Kudo, T., Nishihara, E., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0135 · Cited by 18
Razvi, S., & Gottwald‐Hostalek, U. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1570769 · Cited by 18
Ettleson, M. D., Ibarra, S., Wan, W., Peterson, S., Laiteerapong, N., & Bianco, A. C. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad331 · Cited by 17
Self-citationIdrees, T., Prieto, W. H., Casula, S., Ajith, A., Ettleson, M., Narchi, F. A. A., Russo, P. S. T., Fernandes, F., Johnson, J., Mayampurath, A., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab038 · Cited by 17
Self-citationComorbidities of hypothyroidism
Brenta, G., & Gottwald‐Hostalek, U. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2476075 · Cited by 17
Biondi, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02302 · Cited by 17
Levothyroxine treatment and cholesterol in hypothyroidism
Bianco, A. C., & Taylor, P. N. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0323-2 · Cited by 17
Self-citationThyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil
Penna, G. C., Bensenor, I. M., Bianco, A. C., & Ettleson, M. D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae139 · Cited by 16
Self-citationBiondi, B., Pucci, M., Pontieri, G., Formisano, P., & Esposito, R. (2023) · Thyroid · doi:10.1089/thy.2023.0135 · Cited by 15
Payer, J., Jackuliak, P., Kužma, M., Džupon, M., & Vaňuga, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1067029 · Cited by 15
Mele, C., Tagliaferri, A., Pagano, L., Soranna, D., Scacchi, M., Aimaretti, G., Biondi, B., & Marzullo, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00773 · Cited by 15
Effect of restoration of euthyroidism on visfatin concentrations and body composition in women
Sawicka‐Gutaj, N., Zybek‐Kocik, A., Kloska, M., Ziółkowska, P., Czarnywojtek, A., Sowiński, J., Mańkowska‐Wierzbicka, D., & Ruchała, M. (2021) · Endocrine Connections · doi:10.1530/ec-21-0059 · Cited by 14
LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
Azizi, F., Amouzegar, A., Mehran, L., & Abdi, H. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.100870 · Cited by 14
Greco, M., FOTI, D. P., Aversa, A., Fuíano, G., Brunetti, A., & Simeoni, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092958 · Cited by 13
Larsen, C. B., Winther, K. H., Cramon, P. K., Rasmussen, Å. K., Feldt‐Rasmussen, U., Grøenvold, M., Bjørner, J. B., Hegedűs, L. D., Watt, T., & Bonnema, S. J. (2023) · Thyroid Research · doi:10.1186/s13044-023-00178-0 · Cited by 12
Luongo, C., De Stefano, M. A., Ambrosio, R., Volpe, F., Porcelli, T., Golia, V., Bellevicine, C., Troncone, G., Masone, S., Damiano, V., et al. (2023) · Thyroid · doi:10.1089/thy.2022.0472 · Cited by 11
Hippocampal NLRP1 inflammasome mediates anxiety-like behavior in mice with hypothyroidism
Cheng, Y., Zou, Z.-H., Lou, C.-L., Tong, M.-R., Li, J.-K., Zhu, W.-H., Lu, Y., Zhu, D.-F., Xu, Q., & Xu, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-00979-3 · Cited by 11
Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism
Brokhin, M., Danzi, S. E., & Klein, I. L. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00631 · Cited by 11
Takahashi, S., Ito, M., Masaki, Y., Okazaki‐Hada, M., Minakata, M., Kohsaka, K., Nakamura, T., Kasahara, T., Kudo, T., Nishihara, E., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0542 · Cited by 10
Therapie mit Schilddrüsenhormonen im Alter
Iwen, K. A., & Brabant, G. E. (2020) · Der Internist · doi:10.1007/s00108-020-00790-4 · Cited by 10
Bjerkreim, B. A., Hammerstad, S. S., Gulseth, H. L., Berg, T. J., Lee-Ødegård, S., & Eriksen, E. F. (2022) · Journal of Thyroid Research · doi:10.1155/2022/6423023 · Cited by 8
Gökkaya, N., & Aydın, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-78185-w · Cited by 8
Zamar, A., Lulsegged, A., & Kouimtsidis, C. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.976544 · Cited by 8
Premawardhana, L. D., Taylor, P. N., Okosieme, O. E., Adlan, M. A., Obuobie, E. K., & Dayan, C. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1282608 · Cited by 6
“…subjects on long-term LT4 alone have (a) a 15% excess of psychological caseness (5), a 5% increase in BMI, increased cholesterol and a 25% – 30% increase in cardiovascular and all-cause mortality (10 – 13), and (b) unphysiological T4/T3 ratios with higher T4 than in the normal population (12, 14).”
BackgroundTreatment of Hypothyroidism and Stress Using Neuro-Emotional Technique (NET): A Case Study
Bablis, P., Day, R. R., Bablis, S., & Pollard, H. P. (2024) · Cureus · doi:10.7759/cureus.58231 · Cited by 6
The Frequency of CD4+ T Cells in Women with Hashimoto’s Thyroiditis
Nodehi, M., Ajami, A., Izad, M. H., Asgarian‐Omran, H., Esfahanian, F., Yekaninejad, S., Hemmatabadi, M., Amouzegar, A., Chahardoli, R., Mansouri, F., et al. (2021) · Intern J Endocrinol Metab · doi:10.5812/ijem.110013 · Cited by 5
A New Perspective in the Management of Graves’ Hyperthyroidism
Azizi, F. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.102270 · Cited by 5
Penna, G., Guimarães, R. O., Benseñor, I. M., Ettleson, M. D., Pires, M. C., & Bianco, A. C. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.023 · Cited by 4
Self-citationMuscogiuri, G., Albertelli, M., Arnaldi, G., Barrea, L., Bellastella, G., Bonomi, M., Caputo, M., Caprio, M., Cignarelli, A., Gioia, L. D., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02862-y · Cited by 4
Azizi, F., Moeini, A. S. H., Mehran, L., Masoumi, S., Abdi, H., Foroutan, S. M., Saghafinia, A. E., & Amouzegar, A. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100395 · Cited by 4
Liothyronine use in primary hypothyroidism — current concepts
Concepción‐Zavaleta, M. J., Ildefonso-Najarro, S. P., Paz‐Ibarra, J., Fernández-Dávila, F. V., Condori, D. C. D.-G., Rivera-Fabián, K., Herrera-Cabezas, R. G., & Urteaga, L. A. C. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0093 · Cited by 4
Deiodinase Type 3 Polymorphism (rs1190716) Affects Therapeutic Response to Levothyroxine
Mohmmed, A. H., Hoshi, B., & Jubair, S. (2022) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2022.04876 · Cited by 4
Hadi, Z. M., Alidrisi, H. A., & Mansour, A. A. (2024) · Cureus · doi:10.7759/cureus.58370 · Cited by 4
Investigating the effect of levothyroxine replacement on cholesterol levels in hypothyroid patients
Moradi, L., Zaman, F., Tangestani, M., Amiri, F., & Sedaghat, A. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1008_23 · Cited by 4
Pucci, M., Calzolaio, M., Ghezzi, F., Iannotta, M., Gifuni, M. C., Ruberto, S., Crescenzo, F., Esposito, R., & Biondi, B. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1659736 · Cited by 3
Treatment of Primary Hypothyroidism by Slow-Release Liothyronine Monotherapy
Azizi, F., Amouzegar, A., Abdi, H., Masoumi, S., & Mehran, L. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303321830241227112420 · Cited by 3
The Concept of Cure in Thyroid Diseases
Azizi, F. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.102269 · Cited by 3
Central hypothyroidism: are patients undertreated?
Marlier, J., T'Sjoen, G. G., Kaufman, J., & Lapauw, B. (2022) · European Thyroid Journal · doi:10.1530/etj-21-0128 · Cited by 3
Rolle der bioidenten Schilddrüsenhormone in der Behandlung der Hypothyreose: Ein Update
WEISSEL, M. (2019) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-019-0071-x · Cited by 3
Targeting the right population for T3 + T4 combined therapy: where are we now and where to next?
Porcelli, T., & Salvatore, D. (2020) · Endocrine · doi:10.1007/s12020-020-02391-5 · Cited by 3
Toward Epigenetic Profiling of Thyroid Hormone Status
Hernández, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab141 · Cited by 3
Ma, L., Gou, M., Liu, X., Ding, L., & Ma, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1652749 · Cited by 2
Azizi, F. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.05.005 · Cited by 2
Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism
Zielinski, R., Sacco, S. J., Dillon, M., Katsetos, M., & Celi, F. S. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1847857 · Cited by 2
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
Abdi, H., Zakavi, S. R., & Azizi, F. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.108876 · Cited by 2
Zhang, B., Geng, L., Lin, H., Jia, Q., & Li, T. (2020) · PubMed Central · doi:10.13201/j.issn.2096-7993.2020.06.017 · Cited by 1
Medical Treatment of Hyperthyroidism; Efficacy and Safety Considerations
Azizi, F., Abdi, H., Ebadi, S. A., Mehran, L., & Amouzegar, A. (2025) · Archives of Iranian Medicine · doi:10.34172/aim.33502 · Cited by 1
Ettleson, M. D., Karavolos, K., Burnett‐Bowie, S. M., Jackson, E. A., Thurston, R. C., Khoudary, S. R. E., Karvonen-Gutierrez, C. A., Powell, L. H., & Janssen, İ. (2026) · Thyroid · doi:10.1177/10507256261425625 · Cited by 1
Meneghini, V., Beltrão, F. E. D. L., Ismail, A., Hayek, S. S., Golovko, G., Khanipov, K., Ettleson, M. D., Benseñor, I. M., & Bianco, A. C. (2026) · Thyroid · doi:10.1177/10507256261460759 · Cited by 1
Self-citationIdrees, T., & Bianco, A. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab227 · Cited by 1
Self-citationMartín, J. A. S. (2013) · Tópicos Revista de Filosofía · doi:10.21555/top.v16i1.382
Terapia sostitutiva tiroidea e risposta tissutale: quando il TSH non basta
Monzani, M. L., Piccinini, F., Simoni, M., & Brigante, G. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00775-3
Kotwal, A., Murad, M. H., & Alahdab, F. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab228
Chavez, C. P., & Ospina, N. S. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.346-349
Sawicka‐Gutaj, N., Zybek‐Kocik, A., Kloska, M., Czarnywojtek, A., Ziółkowska, P., Sowiński, J., Mańkowska‐Wierzbicka, D., & Ruchała, M. (2020) · doi:10.21203/rs.3.rs-25942/v1
Principles of Hormone Replacement
Ross, R. J. M. (2022) · doi:10.1093/med/9780198870197.003.0012
7 Medical Management of Thyroiditis and Hypothyroidism
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-182782
Hypothyroidism and Levothyroxine, Review Article
Akhtar, W., Moghal, F. A., Ishaq, M., Naseem, A., Rana, A. H., Nadeem, H., Huda, M. N. U., Barki, K. M. E., Naseem, S., & Shaikh, M. Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164630
Relationship Between Hypothyroid and High LDL Cholesterol
-, M. R. S., & -, P. D. M. A. G. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i04.5708
Hsu, C., Lin, C.-H., Liu, P., & Lin, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-3932875/v1
Vicuña-Herrera, I., Fernández‐Verdejo, R., & Galgani, J. E. (2024) · Revista chilena de nutrición · doi:10.4067/s0717-75182024000200103
Thyroid Problems Encountered Specifically in Inpatients with Cardiac Disease
Shainker, N., Sandeep, J., & Hennessey, J. V. (2025) · Springer eBooks · doi:10.1007/978-3-031-86099-7_9
Larsen, C. B., Winther, K. H., Cramon, P. K., Rasmussen, Å. K., Feldt‐Rasmussen, U., Groenvold, M., Bjorner, J. B., Hegedüs, L., Watt, T., & Bonnema, S. J. (2024) · Figshare · doi:10.6084/m9.figshare.26614339
Integrating metabolomics and genomics to identify biomarkers and drug targets for diseases
Chen, Y. (2024) · eScholarship@McGill (McGill) · doi:10.82308/17138
Hsu, C.-W., Lin, C.-H., Liu, P., & Lin, Y.-H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1721865
КЛІНІКО-ФАРМАКОЛОГІЧНІ ОСОБЛИВОСТІ ЗАСТОСУВАННЯ ЛЕВОТИРОКСИНУ НАТРІЮ У ЗАМІСНІЙ ТЕРАПІЇ ГІПОТИРЕОЗУ
Чала, С., & Привалко, Е. (2026) · Перспективи та інновації науки · doi:10.52058/2786-4952-2025-12(58)-3022-3035
Wang, Y., Zhu, J., Li, Z., Yu, F., Fu, Y., Gao, H., Wang, M., Yuan, L., Zheng, L., & He, Q. (2026) · Cell Transplantation · doi:10.1177/09636897261418754
Геннадьевна, Р. Е., Моргунова, Т. Б., Ryzhkov, I., & Fadeyev, V. (2026) · Vrach · doi:10.29296/25877305-2026-05-13
Yoon, J. H., Shin, D. Y., Kim, H. K., Attanasio, R., Papini, E., Perros, P., Nagy, E. V., Hegedűs, L. D., Kim, S. W., & Kang, H. (2026) · Endocrinology and Metabolism · doi:10.3803/enm.2025.2868
Metadata
- Authors
- McAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C.
- Affiliations
- Rush University Medical Center (US)
- University of California, Davis (US)
- Northwestern University (US)
- University of Chicago (US)
- Corresponding author
- McAninch, Elizabeth A
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-08-15
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6226605
- OpenAlex
- W2887724139
- Cited by
- 94
- References
- 113
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 12 · 2020: 16 · 2019: 14 · 2018: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Rush University
- National Institutes of Health
- National Institute on Aging (P30AG010129, RF1AG057532, R01AG051635)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065055)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- levothyroxine, overt hypothyroidism, thyroid hormone signaling, serum LDL cholesterol, total cholesterol, sex hormone-binding globulin, creatine kinase, ferritin, energy expenditure, renal function, cognitive function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.